AdvisorShares Investments’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $763K | Hold |
83,642
| – | – | 0.14% | 82 |
|
|
2025
Q1 | $657K | Buy |
83,642
+35,842
| +75% | +$282K | 0.13% | 89 |
|
|
2024
Q4 | $260K | Buy |
47,800
+24,470
| +105% | +$133K | 0.05% | 207 |
|
|
2024
Q3 | $168K | Buy |
23,330
+7,300
| +46% | +$52.7K | 0.03% | 226 |
|
|
2024
Q2 | $177K | Buy |
16,030
+1,918
| +14% | +$21.2K | 0.03% | 229 |
|
|
2024
Q1 | $264K | Buy |
14,112
+750
| +6% | +$14.1K | 0.04% | 218 |
|
|
2023
Q4 | $290K | Sell |
13,362
-3,053
| -19% | -$66.2K | 0.07% | 211 |
|
|
2023
Q3 | $338K | Buy |
16,415
+11,188
| +214% | +$230K | 0.09% | 168 |
|
|
2023
Q2 | $246K | Sell |
5,227
-1,023
| -16% | -$48.1K | 0.07% | 190 |
|
|
2023
Q1 | $262K | Sell |
6,250
-889
| -12% | -$37.3K | 0.08% | 175 |
|
|
2022
Q4 | $272K | Sell |
7,139
-2,093
| -23% | -$79.8K | 0.08% | 202 |
|
|
2022
Q3 | $362K | Buy |
+9,232
| New | +$362K | 0.1% | 199 |
|